Moving Mindfully for Freezing of Gait

Not Applicable

Completed

• Conditions: Mindfulness; Parkinson Disease
• Interventions: Behavioral: Mindfulness Based Walking Therapy (MBWT); Other: Freezing of Gait (FOG) Education

• Registration Number: NCT05923229
• Lead Sponsor: Washington University School of Medicine

Brief Summary

The investigators will conduct an randomized controlled trial (RCT) among people with Parkinson disease (PD) and freezing of gait (FOG) to evaluate the feasibility of a mindfulness intervention compared to a educational program about FOG. FOG is a severe motor disturbance that prevents people from stepping normally and is associated with anxiety, frustration, sedentary behaviors, poorer quality of life, and falls. Mindfulness-Based Stress Reduction (MBSR) is an evidence-based practice that creates a culture to reduce stress and anxiety by increasing conscious awareness and self-compassion. In this study, the investigators will develop a mindfulness-based walking intervention to address both mental health and mobility challenges that constitute FOG.

Detailed Description

Conduct pilot randomized clinical trial to evaluate feasibility and acceptability of the standardized Mindfulness Based Walking Therapy (MBWT) program. Using the standardized MBWT protocol devised during earlier aims of this study, the investigators will randomize 24 people with PD+FOG to MBWT or usual care (i.e., medical management and FOG education), examining feasibility elements. The investigators will also conduct follow-up evaluations to monitor burden and continued usage of mindfulness.

Study Timeline

• Study Start: 2023-06-07
• Study First Submitted: 2023-06-19
• Study First Submitted QC: 2023-06-19
• Study First Posted: 2023-06-28
• Primary Completion: 2024-04-26
• Study Completion: 2024-04-26
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-23
• Last Update Posted: 2024-07-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• diagnosed by a neurologist with idiopathic Parkinson disease;
• age 55 and older;
• a score on the Hoehn & Yahr (H&Y) scale between I-IV;
• history of freezing of gait;
• able to provide informed consent;
• experience fear or worry in relation to their freezing of gait;
• able to walk independently with or without an assistive device for at least five minutes; and
• stable medication regimen for one month prior to enrollment.

Exclusion Criteria

• have evidence of dementia (Montreal Cognitive Assessment (MOCA) < 18) to ensure understanding of materials;
• are under consideration for deep brain stimulation surgery within the next six months; neurologic condition other than PD;
• inability to cooperate with the protocol;
• language, visual, or hearing barriers to participation; or
• history of orthopedic or other medical problems that limit ability to participate safely in the intervention.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Mindfulness-Based Walking Therapy (MBWT)	Mindfulness Based Walking Therapy (MBWT)	Participants will receive the MBWT intervention.
Freezing of Gait (FOG) Education	Freezing of Gait (FOG) Education	Participants will receive educational materials about FOG and track their usual care.

Primary Outcome Measures

Name	Time	Method
Recruitment of Sample: Number of Participants Recruited	14 weeks	The investigators will count the number of participants recruited to determine if the feasibility objective of recruitment is met. The investigators benchmark for recruitment is defined as recruiting a target sample of 24 participants to randomize.
Adherence: Number of Hours Participants Practice Mindfulness at Home	14 weeks	The investigators will ask participants to track the number of hours spent practicing mindfulness at home to determine if the feasibility objective of adherence is met. The investigators benchmark for adherence is defined as participants completing 70% of daily home assignment hours.
Attendance of Participants: Number of Participants at Each Session	14 weeks	The investigators will count the number of participants at each session to determine if the feasibility objective of attendance is met. The investigators benchmark for attendance is defined as at least 80% of participants attending each session.
Retention of Participants: Number of Sessions Each Participant Completes	14 weeks	The investigators will count the number of sessions each participant attends to determine if the feasibility objective of retention is met. The investigators benchmark for retention is defined as participants 80% of the sessions.

Trial Locations

Locations (1)

Washington University School of Medicine; 🇺🇸 Saint Louis, Missouri, United States